Completed PHASE4 INTERVENTIONAL 4-arm NCT01093001

Tricuspid Regurgitation Study

The Effect of Cardiac Pacing Leads on Tricuspid Regurgitation

Sponsor: Abbott Medical Devices

Conditions Left Ventricular Dysfunction Right Ventricular Dysfunction Tricuspid Regurgitation

Interventions Echo

Updated 6 times since 2017 Last updated: Nov 2, 2016 Started: May 31, 2010 Primary completion: Sep 30, 2015 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01093001, this PHASE4 trial focuses on Left Ventricular Dysfunction and Right Ventricular Dysfunction and remains completed. Sponsored by Abbott Medical Devices, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Feb 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Feb 2019 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices
Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States